The Asia-Pacific OTC drug market is anticipated to grow at a CAGR of 7.9% during the forecast period. The market growth is attributed to the increasing shift of consumers towards self-medication, product innovation coupled with the focus of pharmaceutical companies to bring new products to the market. Further, the increasing healthcare expenditure, unhealthy dietary habits, growing population base in countries such as India and China further gives a boost to the growth of the Asia-Pacific OTC drug market.
The Asia-Pacific OTC drugs market is segmented based on product type and distribution channels. Based on the product type, the market is sub-segmented into the analgesics & pain relievers; cough, cold & flu products; vitamin & mineral supplements; ophthalmic products; and others. Vitamin & mineral supplements segment is estimated to exhibit a considerable growth rate during the forecast period owing to the increasing awareness among the general population regarding health.
Based on the distribution channel, the market is bifurcated into retail & supermarkets, and online platform. The online distribution channel is estimated to grow at a significant rate during the forecast period owing to the growing e-commerce industry coupled with increasing internet penetration. Further, the report covers the country-level analysis of China, Japan, India, and the Rest of Asia-Pacific. India is an emerging market in the OTC drugs landscape. Some of the common OTC drugs available in India include Aspirin, Ibuprofen, naproxin, paracetamol, and others.
To Request a Sample of our Report on Asia-Pacific OTC Drugs Market: https://www.omrglobal.com/request-sample/asia-pacific-over-the-counter-otc-drugs-market
Asia-Pacific OTC Drugs Market Segment
By Distribution Channel
- Retail & Supermarket
- Online Platform
A full Report of Asia-Pacific OTC Drugs Market is Available @ https://www.omrglobal.com/industry-reports/asia-pacific-over-the-counter-otc-drugs-market
Regional Analysis
- China
- Japan
- India
Rest of Asia-Pacific
Company Profiles
- Cipla Ltd.
- Overview
- Cipla Ltd. in OTC Drugs Landscape
- Recent Developments
- Dabur India Limited
- Emami Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson Services Inc.
- Novartis International AG
- Sun Pharmaceuticals Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- The Piramal Group
- The Procter & Gamble Co.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
